Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Reducing disease burden in an influenza pandemic by targeted delivery of neuraminidase inhibitors: mathematical models in the Australian context

Fig. 1

Assumed clinical pathway in the model, reflecting predestined clinical course and potential points of intervention. Dashed arrows indicate outflows that are only a fraction of the inflow; percentages shown are for the general population, and the values may differ for other strata (e.g., High-Risk, see Table 3). Shaded boxes indicate compartments with residence times greater than one day (i.e., where available capacity is determined by prevalence, not incidence)

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us